Gonadotroph adenomas.
Samuels
M H
MH
Clinical Research Center, Oregon Health Sciences University School of Medicine, Portland.
D000236:Adenoma / Q000378:metabolism* / Q000628:therapy*; D001971:Bromocriptine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D006728:Hormones / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007018:Hypopituitarism / Q000188:drug therapy / Q000209:etiology; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D010024:Osteoporosis / Q000209:etiology / Q000517:prevention & control; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000628:therapy*
D018491:Dopamine Agonists; D006728:Hormones; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004298:Dopamine